SKU: C-1205-5mg
LY-2835219 (Abemaciclib) Chemical Formula: C27H32F2N8
  • Catalog#: C-1205
  • Targets: CDK
  • Synonym: LY2835219; LY2835219; LY 2835219; Abemaciclib
  • Chemical Name/IUPAC:N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine
    Technical Data
  • Product Name: LY-2835219 (Abemaciclib)
  • Chemical Formula: C27H32F2N8
  • Molecular Weight: 506.59
  • CAS#: 1231929-97-7 (free base)
  • Appearance: Solid powder
  • Purity: > 99% by HPLC
  • Solubility: Soluble in DMSO
  • Storage: Room temperature for months, or -20ºC for 3 years
    LY-2835219 (Abemaciclib) is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. LY-2835219 specifically inhibits CDK4/6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth.